AstraZeneca is investing $18 million in Immunai Inc to use AI to improve the efficiency of cancer drug trials.
CANCER DRUG TRIALS
Popular Posts
Level 1, Devonshire House, One Mayfair Place, London, UK
Can we store cookies?
We use cookies to enhance services, personalize content, and analyze traffic. This involves sharing data with social media, advertising, and analytics partners. By using our website, you agree to the placement of cookies as described in our Cookie Policy. Learn more about our use of cookies and your choices in our Cookie Policy
Accept All
Decline All